Open Access Highly Accessed Research article

Metabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care

Joan-Josep Cabré1*, Francisco Martín1, Bernardo Costa2, Josep L Piñol6, Josep L Llor3, Yolanda Ortega4, Josep Basora6, Marta Baldrich1, Rosa Solà7, Jordi Daniel6, Josep Ma Hernández1, Judit Saumell4, Jordi Bladé6, Ramon Sagarra1, Teresa Basora6, Dolors Montañés1, Joan L Frigola1, Angel Donado-Mazarrón2, Maria Teresa García-Vidal4, Isabel Sánchez-Oro2, Josep M de Magriñà4, Ana Urbaneja5, Francisco Barrio2, Jesús Vizcaíno1, Josep M Sabaté1, Irene Pascual1 and Vanesa Revuelta1

Author Affiliations

1 ABS Reus-1, Camí de Riudoms, 53–55, 43202 Reus, Spain

2 ABS Reus-2, Camí de Riudoms 53–55, 43202 Reus, Spain

3 ABS Deltebre, Avinguda Esportiva, 164, 43580 Deltebre, Spain

4 ABS Reus-4, General Moragues 52, 43201 Reus, Spain

5 ABS Reus-3, General Moragues 52, 43201 Reus, Spain

6 Reus-Altebrat Primary Care Service, Spain

7 Medicine Faculty, Rovira i Virgili University, Sant Llorenç 11, 43202 Reus, Spain

For all author emails, please log on.

BMC Public Health 2008, 8:251  doi:10.1186/1471-2458-8-251

Published: 22 July 2008


To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 ± 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 ± 10% and 8.8 ± 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26–5.37), 2.28 (95%CI: 1.84–4.90) and 2.26 (95%CI: 1.48–3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care.